These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1883 related items for PubMed ID: 27072860

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
    Zakeri R, Borlaug BA, McNulty SE, Mohammed SF, Lewis GD, Semigran MJ, Deswal A, LeWinter M, Hernandez AF, Braunwald E, Redfield MM.
    Circ Heart Fail; 2014 Jan; 7(1):123-30. PubMed ID: 24162898
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.
    Borlaug BA, Lewis GD, McNulty SE, Semigran MJ, LeWinter M, Chen H, Lin G, Deswal A, Margulies KB, Redfield MM.
    Circ Heart Fail; 2015 May; 8(3):533-41. PubMed ID: 25782985
    [Abstract] [Full Text] [Related]

  • 8. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
    AbouEzzeddine OF, McKie PM, Dunlay SM, Stevens SR, Felker GM, Borlaug BA, Chen HH, Tracy RP, Braunwald E, Redfield MM.
    J Am Heart Assoc; 2017 Feb 18; 6(2):. PubMed ID: 28214792
    [Abstract] [Full Text] [Related]

  • 9. Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure.
    Legris V, Thibault B, Dupuis J, White M, Asgar AW, Fortier A, Pitre C, Bouabdallaoui N, Henri C, O'Meara E, Ducharme A, EARTH Investigators.
    ESC Heart Fail; 2022 Feb 18; 9(1):450-464. PubMed ID: 34953062
    [Abstract] [Full Text] [Related]

  • 10. Right ventricular function in heart failure with preserved ejection fraction: a community-based study.
    Mohammed SF, Hussain I, AbouEzzeddine OF, Takahama H, Kwon SH, Forfia P, Roger VL, Redfield MM.
    Circulation; 2014 Dec 23; 130(25):2310-20. PubMed ID: 25391518
    [Abstract] [Full Text] [Related]

  • 11. Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload.
    Borgdorff MA, Bartelds B, Dickinson MG, van Wiechen MP, Steendijk P, de Vroomen M, Berger RM.
    Am J Physiol Heart Circ Physiol; 2014 Aug 01; 307(3):H361-9. PubMed ID: 24878769
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study.
    Guazzi M, Vicenzi M, Arena R, Guazzi MD.
    Circulation; 2011 Jul 12; 124(2):164-74. PubMed ID: 21709061
    [Abstract] [Full Text] [Related]

  • 14. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
    Hoendermis ES, Liu LC, Hummel YM, van der Meer P, de Boer RA, Berger RM, van Veldhuisen DJ, Voors AA.
    Eur Heart J; 2015 Oct 07; 36(38):2565-73. PubMed ID: 26188003
    [Abstract] [Full Text] [Related]

  • 15. Left Atrial Function Dynamics During Exercise in Heart Failure: Pathophysiological Implications on the Right Heart and Exercise Ventilation Inefficiency.
    Sugimoto T, Bandera F, Generati G, Alfonzetti E, Bussadori C, Guazzi M.
    JACC Cardiovasc Imaging; 2017 Oct 07; 10(10 Pt B):1253-1264. PubMed ID: 28017395
    [Abstract] [Full Text] [Related]

  • 16. Dapagliflozin and Right Ventricular-Pulmonary Vascular Interaction in Heart Failure With Preserved Ejection Fraction: A Secondary Analysis of a Randomized Clinical Trial.
    Reddy YNV, Carter RE, Sorimachi H, Omar M, Popovic D, Alogna A, Jensen MD, Borlaug BA.
    JAMA Cardiol; 2024 Sep 01; 9(9):843-851. PubMed ID: 39046727
    [Abstract] [Full Text] [Related]

  • 17. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
    Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E, RELAX Trial.
    JAMA; 2013 Mar 27; 309(12):1268-77. PubMed ID: 23478662
    [Abstract] [Full Text] [Related]

  • 18. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
    Mohammed SF, Borlaug BA, McNulty S, Lewis GD, Lin G, Zakeri R, Semigran MJ, LeWinter M, Hernandez AF, Braunwald E, Redfield MM.
    Circ Heart Fail; 2014 Jul 27; 7(4):580-9. PubMed ID: 24833648
    [Abstract] [Full Text] [Related]

  • 19. Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure).
    AbouEzzeddine OF, Haines P, Stevens S, Nativi-Nicolau J, Felker GM, Borlaug BA, Chen HH, Tracy RP, Braunwald E, Redfield MM.
    JACC Heart Fail; 2015 Mar 27; 3(3):245-52. PubMed ID: 25742762
    [Abstract] [Full Text] [Related]

  • 20. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L, Lam CSP, Gong L, Chan SP, Sim D, Yeo D, Jaufeerally F, Leong KTG, Ong HY, Ng TP, Richards AM, Arslan F, Ling LH.
    Eur J Heart Fail; 2017 Dec 27; 19(12):1664-1671. PubMed ID: 28597497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 95.